Assignee
ACUITAS THERAPEUTICS INC
CA·25 granted patents·20 pending applications·700 citations·filing 2015–2024
Top patents by PatentIndex Score
45 records- 0199US11648324B2Lipids and lipid nanoparticle formulations for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2021·Granted May 16, 2023·5 cites·6 claims
- 0299US11634379B2Lipids and lipid nanoparticle formulations for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2020·Granted Apr 25, 2023·7 cites·25 claims
- 0399US11040112B2Lipids and lipid nanoparticle formulations for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2018·Granted Jun 22, 2021·26 cites·34 claims
- 0499US10723692B2Lipids and lipid nanoparticle formulations for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2018·Granted Jul 28, 2020·59 cites·34 claims
- 0599US10221127B2Lipids and lipid nanoparticle formulations for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2016·Granted Mar 5, 2019·136 cites·51 claims
- 0699US10166298B2Lipids and lipid nanoparticle formulations for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2016·Granted Jan 1, 2019·125 cites·39 claims
- 0799US9738593B2Lipids and lipid nanoparticle formulations for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2015·Granted Aug 22, 2017·87 cites·47 claims
- 0899US9737619B2Lipids and lipid nanoparticle formulations for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2017·Granted Aug 22, 2017·78 cites·27 claims
- 0998US11453639B2Lipids for lipid nanoparticle delivery of active agentsACUITAS THERAPEUTICS INC·Filed 2020·Granted Sep 27, 2022·16 cites·23 claims
- 1098US11357856B2Lipids for delivery of active agentsACUITAS THERAPEUTICS INC·Filed 2018·Granted Jun 14, 2022·20 cites·20 claims
- 1198US11168051B2Lipids and lipid nanoparticle formulations for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2019·Granted Nov 9, 2021·20 cites·24 claims
- 1298US10106490B2Lipids and lipid nanoparticle formulations for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2017·Granted Oct 23, 2018·71 cites·19 claims
- 1394US11712481B2Lipid nanoparticle formulationsACUITAS THERAPEUTICS INC·Filed 2017·Granted Aug 1, 2023·11 cites·35 claims
- 1494US11639329B2Lipids for use in lipid nanoparticle formulationsACUITAS THERAPEUTICS INC·Filed 2018·Granted May 2, 2023·6 cites·23 claims
- 1594US11542225B2Lipids for use in lipid nanoparticle formulationsACUITAS THERAPEUTICS INC·Filed 2018·Granted Jan 3, 2023·8 cites·24 claims
- 1694US11524932B2Lipids for use in lipid nanoparticle formulationsACUITAS THERAPEUTICS INC·Filed 2018·Granted Dec 13, 2022·8 cites·24 claims
- 1793US11820728B2Carbonyl lipids and lipid nanoparticle formulations for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2018·Granted Nov 21, 2023·4 cites·26 claims
- 1892US12065396B2Lipids for use in lipid nanoparticle formulationsACUITAS THERAPEUTICS INC·Filed 2018·Granted Aug 20, 2024·5 cites·18 claims
- 1992US2025034081A1Novel lipids and lipid nanoparticle formulations for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2091US12129223B2Lipids for use in lipid nanoparticle formulationsACUITAS THERAPEUTICS INC·Filed 2022·Granted Oct 29, 2024·4 cites·26 claims
- 2191US11976019B2Cationic lipids for use in lipid nanoparticlesACUITAS THERAPEUTICS INC·Filed 2021·Granted May 7, 2024·4 cites·27 claims
- 2285US2024075163A1Novel lipids and lipid nanoparticle formulations for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2381US2025084029A1Lipids for use in lipid nanoparticle formulationsACUITAS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2480US2024308952A1Lipids for use in lipid nanoparticle formulationsACUITAS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2579US2025084030A1Lipids for use in lipid nanoparticle formulationsACUITAS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2672US12410121B2Cationic lipids for use in lipid nanoparticlesACUITAS THERAPEUTICS INC·Filed 2024·Granted Sep 9, 2025·0 cites·21 claims
- 2772US12151996B2Lipids for lipid nanoparticle delivery of active agentsACUITAS THERAPEUTICS INC·Filed 2022·Granted Nov 26, 2024·0 cites·22 claims
- 2872US2025188020A1Lipids for use in lipid nanoparticle formulationsACUITAS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2972US2025161227A1Pegylated lipidsACUITAS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3071US2025188016A1Cationic lipid compounds for use in lipid nanoparticlesACUITAS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3171US2022204439A1Lipids and lipid nanoparticle formulations for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3270US2025236586A1Lipids for lipid nanoparticle delivery of active agentsACUITAS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3369US2024122854A1Novel carbonyl lipids and lipid nanoparticle formulations for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3467US12491261B2Lipid nanoparticle formulationsACUITAS THERAPEUTICS INC·Filed 2023·Granted Dec 9, 2025·0 cites·73 claims
- 3565US2024423914A1Amide containing lipidsACUITAS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3662US2024423915A1Lipids for use in lipid nanoparticlesACUITAS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3762US2024417370A1Lipids for use in lipid nanoparticle formulationsACUITAS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3861US2025025427A1Mixed amide ester containing lipids for use in lipid nanoparticlesACUITAS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3959US2025059131A1Fluorinated cationic lipids for use in lipid nanoparticlesACUITAS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4059US2024270679A1Lipids for use in lipid nanoparticle formulationsACUITAS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4157US2025092002A1Fluorinated cationic lipids for use in lipid nanoparticlesACUITAS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4247US2023097090A1Improved lipid nanoparticles for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4346US2019022247A1Lipids and lipid nanoparticle formulations for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 4438US12583816B2Lipids for lipid nanoparticle delivery of active agentsACUITAS THERAPEUTICS INC·Filed 2019·Granted Mar 24, 2026·0 cites·24 claims
- 4536US12329857B2Systems and methods for manufacturing lipid nanoparticles and liposomesACUITAS THERAPEUTICS INC·Filed 2019·Granted Jun 17, 2025·0 cites·24 claims
Join the waitlist — get patent alerts
Get an alert when ACUITAS THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →